Wall Street Experts
ver. ZuMIgo(08/25)
Eledon Pharmaceuticals, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 1
EBIT TTM (mln): -56
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
Rok finansowy |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
inf% |
-100.0% |
0.0% |
0.0% |
0.0% |
Marża brutto |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-inf% |
-52.5% |
-inf% |
-inf% |
-inf% |
0.0% |
EBIT (mln) |
-10 |
-16 |
-23 |
-45 |
-38 |
-13 |
-14 |
-16 |
-18 |
-37 |
8 |
-43 |
0 |
EBIT Δ r/r |
0.0% |
63.2% |
49.0% |
92.9% |
-15.8% |
-65.6% |
7.2% |
14.2% |
15.0% |
99.7% |
-123.0% |
-606.2% |
-100.0% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-15387.5% |
0.0% |
0.0% |
0.0% |
0.0% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-0 |
0 |
0 |
EBITDA (mln) |
-10 |
-16 |
-24 |
-45 |
-38 |
-13 |
-14 |
-12 |
-14 |
-37 |
9 |
-43 |
0 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-11431.7% |
0.0% |
0.0% |
0.0% |
0.0% |
Podatek (mln) |
0 |
0 |
-0 |
0 |
0 |
0 |
-0 |
2 |
-0 |
-2 |
-0 |
0 |
-0 |
Zysk Netto (mln) |
-10 |
-16 |
-23 |
-45 |
-38 |
-13 |
-14 |
-18 |
-23 |
-35 |
-88 |
-40 |
-35 |
Zysk netto Δ r/r |
0.0% |
63.0% |
48.1% |
93.5% |
-15.8% |
-65.4% |
7.2% |
27.1% |
27.6% |
51.3% |
153.6% |
-53.9% |
-12.4% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-19009.2% |
0.0% |
0.0% |
0.0% |
nan |
EPS |
-101.78 |
-165.87 |
-583.36 |
-324.85 |
-1785.21 |
-50.47 |
-28.11 |
-27.27 |
-15.72 |
-2.33 |
-6.13 |
-1.64 |
-0.73 |
EPS (rozwodnione) |
-101.78 |
-165.87 |
-583.36 |
-324.85 |
-1785.21 |
-50.47 |
-28.11 |
-27.27 |
-15.72 |
-2.33 |
-6.13 |
-1.64 |
-0.0728 |
Ilośc akcji (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
15 |
14 |
25 |
49 |
Ważona ilośc akcji (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
15 |
14 |
25 |
485 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |